Radiprodil not checked

GRIN Therapeutics, Inc. · RGH-896

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
6 active
8 in total · 2 in the EU

What this is

How it works
How it works isn't classified yet
How it’s given
“Radiprodil is an orally active, negative allosteric modulator of the NR2B subunit of the NMDA receptor.”In the company’s words, NCT06392009 on ClinicalTrials.gov
Tested for
GRIN-related Neurodevelopmental Disorder, Tuberous Sclerosis Complex, Focal Cortical Dysplasia, GRIN-related Disorders, Hepatic Impairment, GRIN-related Neurodevelopmental Disorder Caused by Variants Characterized as Non-Gain-of-Function
Main trialPhase 3
“The Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled trial followed by an open-label extension to evaluate the efficacy and safety of radiprodil in participants with GRIN-related neurodevelopmental disorder (GRIN-NDD) with a gain-of-function (GoF) genetic variant. This study will enroll two cohorts: one cohort of participants with a minimal number of countable motor seizures (with or without behavioral symptoms) (Phase 3 Cohort 1: Qualifying Seizures Cohort); and a second cohort with disease symptoms but no seizures or fewer…”In the company’s words, NCT07224581 on ClinicalTrials.gov
Other names
RGH-896

Other drugs for Tuberous Sclerosis Complex

All 7 drugs for Tuberous Sclerosis Complex

Coming up4

Changes1

Last 90 days

Trials8

TrialPhaseCompletesWhat it tests
Phase 3Recruiting May 2027 Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
Phase 1/2Active, not recruiting Jun 2026 Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
Phase 1Active, not recruiting 31 Oct 2026 A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult Participants
Phase 1Active, not recruiting Nov 2026 Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
Phase 1Recruiting May 2027 Radiprodil in Participants With Hepatic Impairment
Phase 1Not yet recruiting Oct 2027 A Phase 1b Study of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder Caused by Non-Gain-of-Function Variants
Phase 1Terminated 8 Jul 2025 Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
Phase 1Completed 10 Jul 2025 Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Radiprodil

Following is part of Solo: you see every change to Radiprodil the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in